MetLife Series A Preferred Stock
MET.PRA
5 hedge funds and large institutions have $4.09M invested in MetLife Series A Preferred Stock in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
101% more capital inflows, than outflows
Capital inflows: $312K | Capital outflows: $155K
0.03% more ownership
Funds ownership: 0.75% → 0.78% (+0.03%)
17% less funds holding
Funds holding: 6 → 5 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$191K |
| 2 |
Tower Bridge Advisors
Conshohocken,
Pennsylvania
|
+$121K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AlphaMark Advisors
Ft. Wright,
Kentucky
|
-$155K |
MET.PRA Hedge Fund Activity: Q4 2022 in Review
5 of the 6,245 institutional investors tracked by Wall St. Rank reported a position in MetLife Series A Preferred Stock (MET.PRA) for Q4 2022, worth a combined $4.09M — up 1.9% from $4.01M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MET.PRA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was PNC Financial Services Group, adding an estimated $191K. The largest seller was AlphaMark Advisors, exiting entirely with an estimated $155K sold.
- 5 institutional investors held MetLife Series A Preferred Stock (MET.PRA) as of Q4 2022, down from 6 in Q3 2022.
- Funds reported $4.09M of MetLife Series A Preferred Stock stock for Q4 2022, up 1.9% quarter-over-quarter.
- 0 funds opened new MetLife Series A Preferred Stock positions in Q4 2022 and 1 closed out, a net change of -1 holder.
- The largest MetLife Series A Preferred Stock buyer in Q4 2022 was PNC Financial Services Group, an estimated $191K added.
- The largest MetLife Series A Preferred Stock seller in Q4 2022 was AlphaMark Advisors, an estimated $155K sold.
Based on aggregated 13F filings for Q4 2022.